Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China Pharma Holdings (CPHI) Change in Cash: 2010-2025

Historic Change in Cash for China Pharma Holdings (CPHI) over the last 16 years, with Sep 2025 value amounting to -$357,407.

  • China Pharma Holdings' Change in Cash fell 1631.12% to -$357,407 in Q3 2025 from the same period last year, while for Sep 2025 it was -$451,066, marking a year-over-year increase of 30.73%. This contributed to the annual value of -$796,959 for FY2024, which is 31.48% down from last year.
  • According to the latest figures from Q3 2025, China Pharma Holdings' Change in Cash is -$357,407, which was down 268.32% from $212,344 recorded in Q2 2025.
  • In the past 5 years, China Pharma Holdings' Change in Cash ranged from a high of $4.4 million in Q4 2021 and a low of -$1.5 million during Q2 2022.
  • In the last 3 years, China Pharma Holdings' Change in Cash had a median value of -$99,544 in 2024 and averaged -$160,213.
  • Per our database at Business Quant, China Pharma Holdings' Change in Cash soared by 620.12% in 2021 and then crashed by 1,631.12% in 2025.
  • China Pharma Holdings' Change in Cash (Quarterly) stood at $4.4 million in 2021, then crashed by 101.28% to -$56,327 in 2022, then skyrocketed by 195.81% to $53,967 in 2023, then slumped by 270.13% to -$91,812 in 2024, then tumbled by 1,631.12% to -$357,407 in 2025.
  • Its Change in Cash was -$357,407 in Q3 2025, compared to $212,344 in Q2 2025 and -$214,191 in Q1 2025.